BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7744216)

  • 1. Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM?
    Smits P; Thien T
    Diabetologia; 1995 Jan; 38(1):116-21. PubMed ID: 7744216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of sulphonylurea derivatives.
    Smits P; Bijlstra PJ; Russel FG; Lutterman JA; Thien T
    Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S55-9. PubMed ID: 8864641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing?
    Leibowitz G; Cerasi E
    Diabetologia; 1996 May; 39(5):503-14. PubMed ID: 8739909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channels in the cardiovascular system.
    Pogátsa G
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S91-8. PubMed ID: 8529523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic and other effects of sulphonylurea drugs on the heart.
    Végh A; Papp JG
    Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S43-53. PubMed ID: 8864640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonylurea derivatives in cardiovascular research and in cardiovascular patients.
    Schotborgh CE; Wilde AA
    Cardiovasc Res; 1997 Apr; 34(1):73-80. PubMed ID: 9217875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of sulphonylurea derivatives.
    Smits P
    Diabetologia; 1997 Jul; 40 Suppl 2():S160-1. PubMed ID: 9248730
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical relevance of ATP-dependent potassium channels.
    Ligtenberg JJ; van Haeften TW; Links TP; Smit AJ; Reitsma WD
    Neth J Med; 1995 Nov; 47(5):241-51. PubMed ID: 8544897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ATP-sensitive potassium channels and substances affecting them].
    Pospísilová Y
    Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans.
    Bijlstra PJ; Lutterman JA; Russel FG; Thien T; Smits P
    Diabetologia; 1996 Sep; 39(9):1083-90. PubMed ID: 8877293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcirculatory effects of KATP channel blockade by sulphonylurea derivatives in humans.
    Abbink EJ; Wollersheim H; Netten PM; Russel FG; Lutterman JA; Smits P
    Eur J Clin Invest; 2002 Mar; 32(3):163-71. PubMed ID: 11895467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tolbutamide on vascular ATP-sensitive potassium channels in humans. Comparison with literature data on glibenclamide and glimepiride.
    Bijlstra PJ; Russel FG; Thien T; Lutterman JA; Smits P
    Horm Metab Res; 1996 Sep; 28(9):512-6. PubMed ID: 8911989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in management of diabetes in patients with coronary heart disease.
    Abdella NA
    Med Princ Pract; 2002; 11 Suppl 2():69-74. PubMed ID: 12444313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sulfonylurea controversy: more questions from the heart.
    Brady PA; Terzic A
    J Am Coll Cardiol; 1998 Apr; 31(5):950-6. PubMed ID: 9561992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP sensitive potassium channel and myocardial preconditioning.
    Day YJ; Gao Z; Tan PC; Linden J
    Acta Anaesthesiol Sin; 1999 Sep; 37(3):121-31. PubMed ID: 10609345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sulphonylurea derivatives and the cardiovascular system].
    Filipiak KJ
    Przegl Lek; 2000; 57 Suppl 4():19-22. PubMed ID: 11293225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle.
    Findlay I
    J Pharmacol Exp Ther; 1992 Jul; 262(1):71-9. PubMed ID: 1625214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of sulphonylureas: role of K(ATP) channels.
    Howes LG
    Diabetes Obes Metab; 2000 Apr; 2(2):67-73. PubMed ID: 11220526
    [No Abstract]   [Full Text] [Related]  

  • 19. Sulphonylurea action revisited: the post-cloning era.
    Gribble FM; Reimann F
    Diabetologia; 2003 Jul; 46(7):875-91. PubMed ID: 12819907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.
    Yokoshiki H; Sunagawa M; Seki T; Sperelakis N
    Am J Physiol; 1998 Jan; 274(1):C25-37. PubMed ID: 9458709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.